hMLH1 immunoexpression is related to the degree of epithelial dysplasia in oral leukoplakia

Journal of Oral Pathology and Medicine

Volumn 40, Issue 2, 2011, Pages 153-159

  Caldeira, Patrícia Carlos ^a   Abreu, Mauro Henrique Nogueira Guimarães ^a   Batista, Aline Carvalho ^b   Do Carmo, Maria Auxiliadora Vieira ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

Human MLH1 protein; Immunohistochemistry; Oral leukoplakia

Indexed keywords

PROTEIN MLH1;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DNA REPAIR; EPITHELIUM DYSPLASIA; FEMALE; GENE DUPLICATION; GENOMIC INSTABILITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; PRIORITY JOURNAL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; AGED, 80 AND OVER; DNA MISMATCH REPAIR; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKOPLAKIA, ORAL; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; NUCLEAR PROTEINS; STATISTICS, NONPARAMETRIC;

EID: 79251536513     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2010.00963.x     Document Type: Article

References (26)

1. Neville BW, Day TA. Oral cancer and precancerous lesions. CA Cancer J Clin 2002; 52: 195-215.
2. Scully C, Bagan J. Oral squamous cell carcinoma: overview of current understanding of aetiopathogenesis and clinical implications. Oral Dis 2009; 15: 388-99.
3. Haya-Fernández MC, Bagán JV, Murillo-Cortés J, Poveda-Roda R, Calabuig C. The prevalence of oral leukoplakia in 138 patients with oral squamous cell carcinoma. Oral Dis 2004; 10: 346-8.
4. Napier SS, Speight PM. Natural history of potentially malignant oral lesions and conditions: an overview of the literature. J Oral Pathol Med 2008; 37: 1-10.
5. Van Der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol 2009; 45: 317-23.
6. Warnakulasuriya S, Reibel J, Bouquot J, Dabelsteen E. Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med 2008; 37: 127-33.
7. Pimenta FJ, Cordeiro GT, Pimenta LGGS, et al. Moleculares alterations in the tumor suppressor gene WWOX in oral leukoplakias. Oral Oncol 2008; 44: 753-8.
8. Tanić N, Tanić N, Milasin J, Vukadinović M, Dimitrijević B. Genomic instability and tumor-specific DNA alterations in oral leukoplakias. Eur J Oral Sci 2009; 117: 231-7.
9. Smith J, Rattay T, Mcconkey C, Helliwell T, Mehanna H. Biomarkers in dysplasia of the oral cavity: a systematic review. Oral Oncol 2009; 45: 647-53.
10. Jun SH, Kim TG, Ban C. DNA mismatch repair system. Classical and fresh roles. FEBS J 2006; 273: 1609-19.
11. Kolodner RD, Marsischky GT. Eukaryotic DNA mismatch repair. Curr Opin Genet Dev 1999; 9: 89-96.
12. O'brien V, Brown R. Signalling cell cycle arrest and cell death through the MMR system. Carcinogenesis 2006; 27: 682-92.
13. Paraf F, Gilquin M, Longy M, et al. MLH1 and MSH2 protein immunohistochemistry is useful for detection of hereditary non-polyposis colorectal cancer in young patients. Histopathology 2001; 39: 250-8.
14. Chung DC, Rustgi AK. The hereditary nonpolyposis colorectal cancer syndrome: genetics and clinical implications. Ann Intern Med 2003; 138: 560-70.
15. Ha PK, Pilkington TA, Westra WH, Sciubba J, Sidransky D, Califano JA. Progression of microsatellite instability from premalignant lesions to tumors of the head and neck. Int J Cancer 2002; 102: 615-7.
16. Sengupta S, Chakrabarti S, Roy A, Panda CK, Roychoudhury S. Inactivation of human mutL homolog 1 and mutS homolog 2 genes in head and neck squamous cell carcinoma tumors and leukoplakia samples by promoter hypermethylation and its relation with microsatellite instability phenotype. Cancer 2007; 109: 703-12.
17. Shia J, Ellis NA, Klimstra DS. The utility of immunohistochemical detection of DNA mismatch repair gene proteins. Virchows Arch 2004; 445: 431-41.
18. Fernandes AM, Ramos-Jorge ML, Cardoso SV, Loyola AM, Mesquita RA, Aguiar MC. Immunoexpression of hMSH2 and hMLH1 in oral squamous cell carcinoma and its relationship to histological grades of malignancy. J Oral Pathol Med 2008; 37: 543-8.
19. Zuo C, Zhang H, Spencer HJ, et al. Increased microsatellite instability and epigenetic inactivation of the hMLH1 gene in head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 2009; 141: 484-90.
20. World Health Organization. Tumours of the oral cavity and oropharynx. In: Barnes L, Eveson JW, Reichart P, Sedransky D eds. Pathology & genetics. Head neck tumors. Lyon: IARC Press, 2005; 177-9.
21. Fernandes AM, De Souza VR, Springer CR, et al. Tobacco and inflammation effects in immunoexpression of hMSH2 and hMLH1 in epithelium of oral mucosa. Anticancer Res 2007; 27: 2433-7.
22. Jascur T, Boland CR. Structure and function of the components of the human DNA mismatch repair system. Int J Cancer 2006; 119: 2030-5.
23. Jiricny J. The multifaceted mismatch-repair system. Nat Rev Mol Cell Biol 2006; 7: 335-46.
24. Liu K, Huang H, Mukunyadzi P, Suen JY, Hanna E, Fan CY. Promoter hypermethylation: an important epigenetic mechanism for hMLH1 gene inactivation in head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 2002; 126: 548-53.
25. Puri SK, Si L, Fan CY, Hanna E. Aberrant promoter hypermethylation of multiple genes in head and neck squamous cell carcinoma. Am J Otolaryngol 2005; 26: 12-7.
26. Kujan O, Oliver RJ, Khattab A, Roberts SA, Thakker N, Sloan P. Evaluation of a new binary system of grading oral epithelial dysplasia for prediction of malignant transformation. Oral Oncol 2006; 42: 987-93.